Read Pharmaceutical news articles from recent Pharmaceutical headlines
 
Google
Home » Pharmaceutical Articles » Rebecca Hyde Included in Distinguished Registry


Rebecca Hyde Included in Distinguished Registry

Rebecca Hyde has a demonstrated track record in building, managing and growing successful businesses which service the pharmaceutical and biotechnology industries

    SOMERSET, NJ, May 6, 2011 /Pharmaceutical PR News/ -- Rebecca Hyde, former Partner of Strategyx and Executive Vice President - Global Communications for inVentiv Advance Insights, has been recognized by Cambridge Who's Who for demonstrating dedication, leadership and excellence in the development and implementation of access and reimbursement strategies for complex biologics and pharmaceutical products.

Ms. Hyde is a veteran of the pharmaceutical industry with over 25 years of professional experience. Equipped with a bachelor's degree in chemical engineering, she began her career in specialty chemical manufacturing then rapidly progressed to the development and marketing of pharmaceutical products. Upon leaving Hoechst Marion Roussel (currently Sanofi Aventis), she founded Strategyx, a management consultancy which specialized in the development of access and reimbursement strategies in the U.S. payer market. This consultancy was acquired by inventive Health in 2007. Ms. Hyde continued the development of commercialization strategy capabilities within the inventive Advance Insights organization where she was responsible for the Global Commercialization consulting group.

Finding success through her desire and ability to tackle new challenges, Ms. Hyde looks forward to continuing to assist her clients in appropriately positioning their pharmaceutical products for commercial success in the patient, physician and payer sectors.

About Cambridge Who's Who
With over 400,000 members representing every major industry, Cambridge Who's Who is a powerful networking resource that enables professionals to outshine their competition, in part through effective branding and marketing. Cambridge Who's Who employs similar public relations techniques to those utilized by Fortune 500 companies and makes them cost-effective for members who seek to take advantage of its career enhancement and business advancement services. Cambridge is pleased to welcome its new Executive Director of Global Branding and Networking, Donald Trump Jr., who is eager to share his extensive experience in this arena with members.

Cambridge Who's Who membership provides individuals with a valuable third party endorsement of their accomplishments and gives them the tools needed to brand themselves and their businesses effectively. In addition to publishing biographies in print and electronic form, it offers an online networking platform where members can establish new professional relationships.

For more information, please visit http://www.cambridgeregistry.com.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com
Press Release Contact Information:

Ellen Campbell
Cambridge Who's Who
Public Relations
498 RXR Plaza, West Tower
Uniondale, NY
USA 11556
Voice: 516-535-1515 x4266
Website: Visit Our Website
 
 
PHARMACEUTICAL ARCHIVE SEARCH
 
SUBMIT PHARMACEUTICAL NEWS
Submit your Pharmaceutical story